NCT00224393 2023-05-30
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
The Cleveland Clinic
Phase 2 Completed
Clinical Trials
7 trialsNCT00141726 2015-12-03
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01730495 2015-12-02
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Haukeland University Hospital
Phase 2 Terminated
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown
NCT00509600 2012-08-07
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00217386 2010-09-15
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00005853 2010-04-02
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
Phase 2 Completed